Here Are the 3 Cheapest Magnificent Seven Stocks According to a Popular Metric. Are They Buys?

The article argues that Nvidia, Microsoft, and Meta Platforms remain attractive long-term buys despite valuation and execution concerns, highlighting forward P/E ratios of 23.8x, 24.5x, and 19.3x, respectively. It cites Nvidia's $81.6 billion quarterly revenue, up 85% year over year, Microsoft's planned $190 billion of 2026 capex, and Meta's 3.56 billion-user ecosystem as evidence of durable AI-driven growth. The piece is opinionated commentary rather than new company-specific news, so market impact is likely limited.

Analysis

The market is treating the Magnificent Seven as a single de-rating block, but the setup is actually a dispersion trade: the names with the clearest monetization of AI infrastructure and distribution remain the ones the market is punishing the least. NVDA still looks like the cleanest beneficiary of capex inertia because hyperscalers cannot easily substitute away from its software stack, while MSFT benefits from the same spend through Azure and enterprise lock-in rather than needing AI adoption to prove out in a consumer product cycle. META is more nuanced: the market is discounting capex repetition risk, but that capex is still tied to measurable ad yield improvements, which makes the payback window shorter than the market is pricing.

The second-order effect is that the perceived losers from AI are more likely to be the “adjacent incumbents” than the core platform winners. If inference demand keeps shifting compute toward lower-latency, higher-throughput workloads, vendors with weak software ecosystems will see pricing pressure first, while NVDA/MSFT/META can bundle, distribute, and monetize across multiple surfaces. That argues for continued crowding into the strongest balance sheets rather than trying to fade AI capex broadly; the real vulnerability is not spending itself, but spending that lacks a visible revenue bridge within 2-3 quarters.

Consensus is underestimating how little earnings multiple compression has to do with deterioration in fundamentals here. The real risk is a temporary digestion phase if capex continues to rise faster than near-term revenue reacceleration, especially for MSFT and META over the next 1-2 quarters. But if enterprise AI spend normalizes and backlog/ads metrics continue to inflect, the current valuation reset should look like a buyable air pocket rather than a trend change.

Key Decisions for Investors

• Stay long NVDA into the next 1-2 earnings cycles; risk/reward remains favorable as long as hyperscaler capex stays elevated and software lock-in prevents meaningful share loss.
• Add to MSFT on 3-6 month weakness; the market is pricing capex as a drag, but the better trade is that Azure and enterprise AI attach rates re-accelerate before margins do.
• Buy META on pullbacks with a 6-12 month horizon; asymmetry is strongest if ad efficiency gains offset capex skepticism, but trim if user engagement or ad conversion fails to improve next quarter.
• Consider a relative-value long NVDA / short a basket of weaker AI-adjacent hardware or semicap names; if inference demand broadens, the strongest software moat should outperform the weaker implementation layer.
• Use options for event-driven exposure: call spreads on MSFT or META into the next earnings print to express upside from guidance upgrades while capping downside if capex fears persist.